CRBU Latest Press Releases

-- February 12, 2026 --

Caribou Biosciences to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- February 4, 2026 --

Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT and CIBMTR Globe Newswire 8:00 AM

-- December 24, 2025 --

Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge Globe Newswire 6:00 AM

-- December 1, 2025 --

Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025 Globe Newswire 4:05 PM

-- November 12, 2025 --

Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- November 3, 2025 --

Caribou Biosciences to Participate in Upcoming Investor Conferences Globe Newswire 5:15 PM

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma Globe Newswire 7:00 AM

Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies Globe Newswire 7:00 AM

-- November 2, 2025 --

Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma Globe Newswire 4:00 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software